BENCHMARK PROFILE
Void Research
Latest sync: Oct 3, 2026, 9:44 AM. Source coverage currently reflects PB Evidence data.
REFERRAL OFFER
10% off with disclosed code
Code BENCHMARK = 10% off, tracked via the ?ref=BENCHMARK affiliate link (case-sensitive). Partner program copy leads with the shopper discount; Pricing models a single 10% customer benefit against listed price and does not invent link+code stacking. Partner first-order / recurring commissions are internal only and never enter Pricing math.
PeptideBenchmark has a disclosed affiliate relationship with Void Research. This does not change benchmark scores or trust ratings — it only affects outbound links and pricing-board discount modeling where applicable.
Readers who want a Houston-stated U.S. catalog with house GLP codes mapped on the pricing board and a public COA archive that can be checked at Freedom Diagnostics, ILS Laboratories, or Kovera Labs.
Vendor-stated: established in Houston; [email protected]; text +1 (979) 800-5515; [email protected] for affiliate applications. About copy describes U.S.-based manufacturing and an eight-assay third-party panel before ship. No public street address on contact or about pages. Observed August 20, 2026.
GLP-2 TZ and GLP-3 RT are house codes for tirzepatide and retatrutide. The public COA archive covers a representative subset of the live catalog, not every SKU. Comparable nasal sprays appear in Ready sprays and are not mixed into vial $/mg; reconstitution and support items remain outside Pricing. Standing storefront markdown is vendor marketing and is recorded as the published cart price rather than a PeptideBenchmark coupon. PeptideBenchmark’s disclosed shopper code is BENCHMARK (10% off via ?ref=BENCHMARK).
A Houston-stated U.S. research storefront with openly listed cart prices and a public /coa archive of Freedom Diagnostics, ILS Laboratories, and Kovera Labs certificates that resolve at the issuing laboratories, with Freedom and ILS reports naming the Void Research client.
Void Research sells research-only singles, blends, and nasal sprays with cart prices on the public shop, including house codes GLP-2 TZ for tirzepatide and GLP-3 RT for retatrutide, plus GLOW, KLOW, and BPC/TB blends. The public /coa page publishes Freedom Diagnostics, ILS Laboratories, and Kovera Labs certificates per batch, keeping superseded reports alongside their replacements; PeptideBenchmark confirms printed Freedom Search Codes and the ILS portal verify route (token or printed Access Code) when the client field names Void Research, and Kovera KVR report codes at the laboratory’s public verify endpoint. Comparable nasal sprays appear in Ready sprays; reconstitution and support SKUs remain outside Pricing.
The public /coa archive hosts Freedom Diagnostics, ILS Laboratories, and Kovera Labs Certificate-of-Analysis documents whose Search Codes, portal verify routes, or KVR report codes resolve at the issuing laboratory; Freedom and ILS reports name Void Research in the client field. Published certificates typically support identity, HPLC purity, and net content for the named sample; ILS and Kovera reports add endotoxin and, on covered batches, sterility, heavy-metals, and fentanyl-screen fields. A matched certificate documents the tested sample and does not endorse every vial or unlisted lot.
This vendor is one of 130 names currently included in our manual curated research-vendor layer.
This is the strongest public transparency pattern on the site. The key signal is that readers can leave the vendor domain and inspect reports or verification pages on an outside provider domain without needing to log in.
- Treat the outside provider route as the strongest part of the evidence, not the vendor marketing copy around it.
- Look for repeated product-level behavior across the catalog, not just one showcase example.
- Do not overread it as proof that every current lot is covered or current unless the linked report trail itself supports that.
This vendor makes the most sense when you compare it to other vendors using a similar transparency model, rather than to every vendor on the board at once.
PB Curated Assessment is a PeptideBenchmark-authored rubric built from the trust and transparency review layer. It is separate from the source-derived benchmark score.
Void Research is currently one of the strongest curated cases on the site because readers can inspect a repeatable public evidence trail without logging in.
Readers can leave the vendor marketing layer and inspect verification publicly.
This is the strongest public pattern because the verification step routes into an outside provider layer.
Current review touched 29 products and 48 document/link destinations.
3 named lab signal(s) and 1 certification category signal(s) are currently visible in the reviewed evidence.
Score 9.2 from pb evidence score.
PB Curated Assessment: Strong. This is our own trust/transparency rubric and is kept separate from the PB score.
Under the formula retired on Aug 28, 2026 this vendor scores 9.20 — the live evidence-first score is 8.42 (-0.78). What changed and why: scoring methodology.
Observed from public domain records and the vendor's own site on Aug 27, 2026. Identity facts are shown for context and do not affect scores.
Holding a certificate for this vendor that is not here? Send it to the archive →
Same third-party review signals shown on the vendor board. Click Trustpilot or Pep Review Pro to open the source profile.
PB score is the number you should read first on this page. It starts with trust evidence, pricing coverage, and third-party review signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available. Reviewed transparency evidence contributes a bounded amount — shown as a trust lift for source-benchmarked vendors, and folded into the base score for PB-evidence vendors.
This vendor’s score is evidence-first: verifiable testing evidence forms the backbone, and outside review sources are a bounded adjustment that can warn far more than it can boost. The terms below sum to the displayed score (small rounding aside). Full formula on the scoring methodology page.
WHAT THIS PAGE IS
- Board-ranked vendor profile with source-linked benchmark inputs
- No Finnrick score currently linked
- No Peptide Critic score currently linked
- Includes Trustpilot review coverage
- No Pep Review Pro profile currently linked
CURRENT LIMITS
- Not an original lab test or editorial review
- Source scales and methodologies differ across sites
- Depends on source site freshness and formatting
These are representative public examples from the vendor testing review queue. They show how product pages in the catalog expose public report or verification paths, but they should still be read as examples rather than proof for every current lot.
In other words: the relationship registry above captures the vendor-to-provider link itself, while the examples below show what that link looks like across real product pages.
METHODOLOGY
How to read this benchmark
This profile summarizes public benchmark data synced from Finnrick and, when available, Peptide Critic. Finnrick contributes a 10-point average from its vendor table, while Peptide Critic contributes a 5-star rating that we normalize to a 10-point scale before ranking consensus entries.
A high score can be directionally useful, but it is not a substitute for current COAs, identity testing, chain-of-custody details, or your own due diligence. We are intentionally separating source aggregation from first-party editorial claims.
Scores combine PB trust evidence with external signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available.